Buprenorphine Initiation: Low-Dose Methods #457.
作者信息
Ho J Janet, Jones Katie Fitzgerald, Merlin Jessica S, Sager Zachary, Childers Julie
出版信息
J Palliat Med. 2023 Jun;26(6):867-869. doi: 10.1089/jpm.2023.0047.
PMID:37276524
Abstract
摘要
相似文献
1
Buprenorphine Initiation: Low-Dose Methods #457.
J Palliat Med. 2023 Jun;26(6):867-869. doi: 10.1089/jpm.2023.0047.
2
Low- and very low-dose buprenorphine induction: new(ish) uses for an old(ish) medication?
Addiction. 2022 Jun;117(6):1507-1509. doi: 10.1111/add.15799. Epub 2022 Jan 14.
3
Medication-Based Treatment to Address Opioid Use Disorder.
JAMA. 2019 Jun 4;321(21):2071-2072. doi: 10.1001/jama.2019.5523.
4
Buprenorphine for Persons on Waiting Lists for Treatment for Opioid Dependence.
N Engl J Med. 2017 Mar 9;376(10):1000. doi: 10.1056/NEJMc1700539.
5
Buprenorphine for Persons on Waiting Lists for Treatment for Opioid Dependence.
N Engl J Med. 2017 Mar 9;376(10):1000-1001. doi: 10.1056/NEJMc1700539.
6
Time to include buprenorphine-naloxone combination in the WHO Model List of Essential Medicines.
J Opioid Manag. 2013 Jul-Aug;9(4):237.
7
Enhancing engagement between legislators and nursing to increase buprenorphine access.
Nurs Outlook. 2023 Jul-Aug;71(4):102004. doi: 10.1016/j.outlook.2023.102004. Epub 2023 Jul 8.
8
Novel forms of injectable buprenorphine and French model of opioid use disorder treatment.
Therapie. 2020 Sep-Oct;75(5):393-395. doi: 10.1016/j.therap.2020.09.007. Epub 2020 Sep 28.
9
Buprenorphine for Opioid Use Disorder-An Essential Medical Treatment.
JAMA Intern Med. 2024 Oct 1;184(10):1248-1249. doi: 10.1001/jamainternmed.2024.3977.
10
Rethinking Opioid Dose Tapering, Prescription Opioid Dependence, and Indications for Buprenorphine.
Ann Intern Med. 2019 Sep 17;171(6):427-429. doi: 10.7326/M19-1488. Epub 2019 Aug 27.
引用本文的文献
1
Opioid Risk Mitigation Practices of Interprofessional Oncology Personnel: Results From a Cross-Sectional Survey.
Oncologist. 2023 Nov 2;28(11):996-1004. doi: 10.1093/oncolo/oyad214.
Zotero 插件